Facebook Twitter Instagram You Tube Pinterest LinkedIn RSS Podcasts Video Library Blog
 - Northwestern Memorial Hospital - Chicago

William J. Gradishar, MD

Oncology, Internal Medicine

This physician accepts new patients.Read important legal notice

You may also call Northwestern Memorial's Physician Referral Department at 1.877.926.4NMH(4664) to arrange a new patient appointment.
Office Phone: 312-695-0990
Office Hours:
  • Monday:7:45 a.m. - 2:00 p.m.
  • Tuesday:7:45 a.m. - 2:00 p.m.
  • Wednesday:7:45 a.m. - 2:00 p.m.

Clinical Interests

Breast Cancer

Education and Training

Medical Education:

University of Illinois College of Medicine 1982


Michael Reese Medical Center 1986


University of Chicago Medical Center 1990

Board Certification

Internal Medicine, Medical Oncology

Locations and Directions

250 E. Superior
Prentice 4-420
Chicago, IL 60611 312-695-0990


Dr. William J. Gradishar, M.D., F.A.C.P. is professor of medicine in the division of hematology and medical oncology, department of medicine, at the Feinberg School Medicine at Northwestern University. He is also the Betsy Bramsen Professor of Breast Oncology. His research focuses on the development of the latest therapies for breast cancer treatment. He has published extensively in the area of breast cancer therapy, with a focus on endocrine therapy, chemotherapy and novel targeted therapies.

After receiving his medical degree from the University of Illinois Abraham School of Medicine in Chicago, he completed a residency and chief residency in internal medicine at Michael Reese Hospital and Medical Center in Chicago.  He completed a fellowship in Medical Oncology at the University of Chicago.

Dr. Gradishar is a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He is the Director of the Maggie Daley Center for Women’s Cancer Care and Director of Breast Medical Oncology at Northwestern Memorial Hospital/Northwestern University. In addition, he is a Fellow of the American College of Physicians, a member of the American Association for Cancer Research and the American Federation for Clinical Research. He chairs the Professional Development Committee and is the Chair-elect of the Nominating Committee of the American Society of Clinical Oncology (ASCO) and serves on numerous breast cancer committees in other major oncology organizations, including as a consultant to the Oncology Drug Advisory Committee of the FDA. He has been a member of the Breast Cancer Treatment Guideline Committee and the Breast Cancer Risk Reduction Committee of the National Comprehensive Cancer Network (NCCN) since its inception.


View the full disclosure of external professional relationships